Close

Retrophin (RTRX) Announces Significant Top-Line Data from Sparsentan Phase 2 as FSGS Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. V
6. BA
7. KMB
8. MSFT
9. FI
10. SPY


Go back to Retrophin (RTRX) Announces Significant Top-Line Data from Sparsentan Phase 2 as FSGS Treatment
RETROPHIN (NASDAQ: RTRX) Delayed: 24.25 --0 (-0%)
Previous Close $24.25    52 Week High $24.57 
Open $4.35    52 Week Low $11.60 
Day High $24.25    P/E N/A 
Day Low $24.25    EPS $-4.30 
Volume 217,426